297 related articles for article (PubMed ID: 24606096)
1. Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study.
Patterson BC; Chen Y; Sklar CA; Neglia J; Yasui Y; Mertens A; Armstrong GT; Meadows A; Stovall M; Robison LL; Meacham LR
J Clin Endocrinol Metab; 2014 Jun; 99(6):2030-7. PubMed ID: 24606096
[TBL] [Abstract][Full Text] [Related]
2. Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancer.
Thomas-Teinturier C; Oliver-Petit I; Pacquement H; Fresneau B; Allodji RS; Veres C; Bolle S; Berchery D; Demoor-Goldschmidt C; Haddy N; Diallo I; de Vathaire F
Eur J Endocrinol; 2020 Oct; 183(4):471-480. PubMed ID: 32738133
[TBL] [Abstract][Full Text] [Related]
3. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Neglia JP; Robison LL; Stovall M; Liu Y; Packer RJ; Hammond S; Yasui Y; Kasper CE; Mertens AC; Donaldson SS; Meadows AT; Inskip PD
J Natl Cancer Inst; 2006 Nov; 98(21):1528-37. PubMed ID: 17077355
[TBL] [Abstract][Full Text] [Related]
4. Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience.
Felicetti F; Fortunati N; Garbossa D; Biasin E; Rudà R; Daniele D; Arvat E; Corrias A; Fagioli F; Brignardello E
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1277-82. PubMed ID: 25609074
[TBL] [Abstract][Full Text] [Related]
5. Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review.
Casey DL; Vogelius IR; Brodin NP; Roberts KB; Avanzo M; Moni J; Owens C; Ronckers CM; Constine LS; Bentzen SM; Olch A
Int J Radiat Oncol Biol Phys; 2024 Jun; 119(2):640-654. PubMed ID: 37777927
[TBL] [Abstract][Full Text] [Related]
6. Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.
Swerdlow AJ; Cooke R; Beckers D; Butler G; Carel JC; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Hokken-Koelega ACS; Khan AJ; Kiess W; Kuehni CE; Flück CE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tidblad A; Tollerfield S; Zandwijken GRJ
J Clin Endocrinol Metab; 2019 Mar; 104(3):658-664. PubMed ID: 30137467
[TBL] [Abstract][Full Text] [Related]
7. Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review.
Bowers DC; Nathan PC; Constine L; Woodman C; Bhatia S; Keller K; Bashore L
Lancet Oncol; 2013 Jul; 14(8):e321-8. PubMed ID: 23816298
[TBL] [Abstract][Full Text] [Related]
8. Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
Heymer EJ; Hawkins MM; Winter DL; Teepen JC; Sunguc C; Ronckers CM; Allodji RS; Alessi D; Sugden E; Belle FN; Bagnasco F; Byrne J; Bárdi E; Garwicz S; Grabow D; Jankovic M; Kaatsch P; Kaiser M; Michel G; Schindera C; Haddy N; Journy N; Česen Mazić M; Skinner R; Kok JL; Gunnes MW; Wiebe T; Sacerdote C; Maule MM; Terenziani M; Jakab Z; Winther JF; Lähteenmäki PM; Zadravec Zaletel L; Haupt R; Kuehni CE; Kremer LC; de Vathaire F; Hjorth L; Reulen RC
Br J Cancer; 2024 Apr; 130(6):976-986. PubMed ID: 38243010
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report.
Wells EM; Ullrich NJ; Seidel K; Leisenring W; Sklar CA; Armstrong GT; Diller L; King A; Krull KR; Neglia JP; Stovall M; Whelan K; Oeffinger KC; Robison LL; Packer RJ
Neuro Oncol; 2018 Jan; 20(1):132-142. PubMed ID: 29016809
[TBL] [Abstract][Full Text] [Related]
10. Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study.
Taylor AJ; Little MP; Winter DL; Sugden E; Ellison DW; Stiller CA; Stovall M; Frobisher C; Lancashire ER; Reulen RC; Hawkins MM
J Clin Oncol; 2010 Dec; 28(36):5287-93. PubMed ID: 21079138
[TBL] [Abstract][Full Text] [Related]
11. Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.
Bowers DC; Moskowitz CS; Chou JF; Mazewski CM; Neglia JP; Armstrong GT; Leisenring WM; Robison LL; Oeffinger KC
J Clin Oncol; 2017 May; 35(14):1570-1576. PubMed ID: 28339329
[TBL] [Abstract][Full Text] [Related]
12. GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution.
Brignardello E; Felicetti F; Castiglione A; Fortunati N; Matarazzo P; Biasin E; Sacerdote C; Ricardi U; Fagioli F; Corrias A; Arvat E
J Endocrinol Invest; 2015 Feb; 38(2):171-6. PubMed ID: 25344310
[TBL] [Abstract][Full Text] [Related]
13. Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS.
Woodmansee WW; Zimmermann AG; Child CJ; Rong Q; Erfurth EM; Beck-Peccoz P; Blum WF; Robison LL;
Eur J Endocrinol; 2013 Apr; 168(4):565-73. PubMed ID: 23359434
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.
Armstrong GT; Liu Q; Yasui Y; Huang S; Ness KK; Leisenring W; Hudson MM; Donaldson SS; King AA; Stovall M; Krull KR; Robison LL; Packer RJ
J Natl Cancer Inst; 2009 Jul; 101(13):946-58. PubMed ID: 19535780
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors of Subsequent Central Nervous System Tumors after Childhood and Adolescent Cancers: Findings from the French Childhood Cancer Survivor Study.
Journy NMY; Zrafi WS; Bolle S; Fresneau B; Alapetite C; Allodji RS; Berchery D; Haddy N; Kobayashi I; Labbé M; Pacquement H; Pluchart C; Schwartz B; Souchard V; Thomas-Teinturier C; Veres C; Vu-Bezin G; Diallo I; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):133-141. PubMed ID: 33033142
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor.
Ergun-Longmire B; Mertens AC; Mitby P; Qin J; Heller G; Shi W; Yasui Y; Robison LL; Sklar CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3494-8. PubMed ID: 16822820
[TBL] [Abstract][Full Text] [Related]
17. Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy.
Tsui K; Gajjar A; Li C; Srivastava D; Broniscer A; Wetmore C; Kun LE; Merchant TE; Ellison DW; Orr BA; Boop FA; Klimo P; Ross J; Robison LL; Armstrong GT
Neuro Oncol; 2015 Mar; 17(3):448-56. PubMed ID: 25395462
[TBL] [Abstract][Full Text] [Related]
18. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
Meadows AT; Friedman DL; Neglia JP; Mertens AC; Donaldson SS; Stovall M; Hammond S; Yasui Y; Inskip PD
J Clin Oncol; 2009 May; 27(14):2356-62. PubMed ID: 19255307
[TBL] [Abstract][Full Text] [Related]
19. Social adjustment in adolescent survivors of pediatric central nervous system tumors: A report from the Childhood Cancer Survivor Study.
Schulte F; Brinkman TM; Li C; Fay-McClymont T; Srivastava DK; Ness KK; Howell RM; Mueller S; Wells E; Strother D; Lafay-Cousin L; Leisenring W; Robison LL; Armstrong GT; Krull KR
Cancer; 2018 Sep; 124(17):3596-3608. PubMed ID: 30067866
[TBL] [Abstract][Full Text] [Related]
20. Radiation risk of central nervous system tumors in the Life Span Study of atomic bomb survivors, 1958-2009.
Brenner AV; Sugiyama H; Preston DL; Sakata R; French B; Sadakane A; Cahoon EK; Utada M; Mabuchi K; Ozasa K
Eur J Epidemiol; 2020 Jun; 35(6):591-600. PubMed ID: 31982981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
